{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:01:50Z","timestamp":1789243310296,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To assess the primary safety and oncological outcome of percutaneous cryoablation in patients with non-visceral metastases of the abdominal cavity after prior surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All patients with non-visceral metastases after prior abdominal surgery, treated with percutaneous cryoablation, and at least one year of follow-up were retrospectively identified. Technical success was achieved if the ice-ball had a minimum margin of 10\u00a0mm in three dimensions on the per-procedural CT images. Complications were recorded using the Society of Interventional Radiology (SIR) classification system. Time until disease progression was monitored with follow-up CT and\/or MRI. Local control was defined as absence of recurrence at the site of ablation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eleven patients underwent cryoablation for 14 non-visceral metastases (mean diameter 20\u2009\u00b1\u20099\u00a0mm). Primary tumor origin was renal cell (<jats:italic>n<\/jats:italic>\u2009=\u20094), colorectal (<jats:italic>n<\/jats:italic>\u2009=\u20093), granulosa cell (<jats:italic>n<\/jats:italic>\u2009=\u20092), endometrium (<jats:italic>n<\/jats:italic>\u2009=\u20091) and appendix (<jats:italic>n<\/jats:italic>\u2009=\u20091) carcinoma. Treated metastases were localized retroperitoneal (<jats:italic>n<\/jats:italic>\u2009=\u20098), intraperitoneal (<jats:italic>n<\/jats:italic>\u2009=\u20092), or in the abdominal wall (<jats:italic>n<\/jats:italic>\u2009=\u20094). Technical success was achieved in all procedures. After a median follow-up of 27\u00a0months (12\u201338\u00a0months), all patients were alive. Local control was observed in 10\/14 non-visceral metastases, and the earliest local progression was detected after ten months. No major adverse events occurred. One patient suffered a minor asymptomatic adverse event.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This proof-of-concept study suggests that cryoablation can be a minimal invasive treatment option in a selected group of patients with non-visceral metastases in the abdominal cavity after prior surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00261-022-03598-y","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T10:02:52Z","timestamp":1656756172000},"page":"3345-3352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Percutaneous cryoablation: a novel treatment option in non-visceral metastases of the abdominal cavity after prior surgery"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4535-9810","authenticated-orcid":false,"given":"D. J.","family":"van der Reijd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. R.","family":"Baetens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gomez Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M.","family":"Aarts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Lahaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. M.","family":"Graafland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A. R.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G. J.","family":"Aalbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. F. M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. G. H.","family":"Beets-Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. G.","family":"Klompenhouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,2]]},"reference":[{"issue":"6","key":"3598_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/aje\/kww245","volume":"186","author":"TL Lash","year":"2017","unstructured":"T.L. Lash, A.H. Riis, E.B. Ostenfeld, R. Erichsen, M. Vyberg, T.P. Ahern, O. Thorlacius-Ussing, Associations of Statin Use With Colorectal Cancer Recurrence and Mortality in a Danish Cohort, Am J Epidemiol 186(6) (2017) 679-687.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"3598_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.surg.2006.07.020","volume":"141","author":"H Kobayashi","year":"2007","unstructured":"H. Kobayashi, H. Mochizuki, K. Sugihara, T. Morita, K. Kotake, T. Teramoto, S. Kameoka, Y. Saito, K. Takahashi, K. Hase, M. Oya, K. Maeda, T. Hirai, M. Kameyama, K. Shirouzu, T. Muto, Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study, Surgery 141(1) (2007) 67-75.","journal-title":"Surgery"},{"issue":"1469","key":"3598_CR3","first-page":"51","volume":"131","author":"A Gunawardene","year":"2018","unstructured":"A. Gunawardene, B. Desmond, A. Shekouh, P. Larsen, E. Dennett, Disease recurrence following surgery for colorectal cancer: five-year follow-up, N Z Med J 131(1469) (2018) 51-58.","journal-title":"N Z Med J"},{"issue":"35","key":"3598_CR4","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1200\/JCO.2015.61.8009","volume":"33","author":"SB Stewart-Merrill","year":"2015","unstructured":"S.B. Stewart-Merrill, R.H. Thompson, S.A. Boorjian, S.P. Psutka, C.M. Lohse, J.C. Cheville, B.C. Leibovich, I. Frank, Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach, J Clin Oncol 33(35) (2015) 4151-7.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3598_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/iju.12996","volume":"23","author":"K Kobayashi","year":"2016","unstructured":"K. Kobayashi, T. Saito, Y. Kitamura, V. Bilim, T. Toba, T. Kawasaki, N. Hara, T. Tanikawa, Y. Tomita, Clinicopathological features and outcomes in patients with late recurrence of renal cell carcinoma after radical surgery, Int J Urol 23(2) (2016) 132-7.","journal-title":"Int J Urol"},{"key":"3598_CR6","unstructured":"N.H. Azawi, H. Tesfalem, K.S. Mosholt, P. H\u00f8yerup, E.S. Jensen, E. Malchau, M. Fode, Recurrence rates and survival in a Danish cohort with renal cell carcinoma, Dan Med J 63(4) (2016)."},{"key":"3598_CR7","doi-asserted-by":"crossref","unstructured":"C.S. Morris, M.O. Baerlocher, S.R. Dariushnia, E.D. McLoney, N. Abi-Jaoudeh, K. Nelson, M. Cura, A.K. Abdel Aal, J.W. Mitchell, S. Madassery, S. Partovi, T.D. McClure, A.L. Tam, S. Patel, Society of Interventional Radiology Position Statement on the Role of Percutaneous Ablation in Renal Cell Carcinoma: Endorsed by the Canadian Association for Interventional Radiology and the Society of Interventional Oncology, J Vasc Interv Radiol 31(2) (2020) 189\u2013194.e3.","DOI":"10.1016\/j.jvir.2019.11.001"},{"issue":"7","key":"3598_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jtho.2020.02.022","volume":"15","author":"MR Callstrom","year":"2020","unstructured":"M.R. Callstrom, D.A. Woodrum, F.C. Nichols, J. Palussiere, X. Buy, R.D. Suh, F.G. Abtin, B.B. Pua, D.C. Madoff, S.L. Bagla, D.C. Papadouris, H.C. Fernando, D.E. Dupuy, T.T. Healey, W.H. Moore, T.V. Bilfinger, S.B. Solomon, H. Yarmohammadi, H.J. Krebs, C.J. Fulp, A. Hakime, L. Tselikas, T. de Baere, Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation (SOLSTICE), J Thorac Oncol 15(7) (2020) 1200-1209.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"3598_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12032-016-0848-3","volume":"33","author":"RL Cazzato","year":"2016","unstructured":"R.L. Cazzato, J. Garnon, N. Ramamurthy, G. Koch, G. Tsoumakidou, J. Caudrelier, F. Arrigoni, L. Zugaro, A. Barile, C. Masciocchi, A. Gangi, Percutaneous image-guided cryoablation: current applications and results in the oncologic field, Med Oncol 33(12) (2016) 140.","journal-title":"Med Oncol"},{"key":"3598_CR10","doi-asserted-by":"crossref","unstructured":"M. Dijkstra, S. Nieuwenhuizen, R.S. Puijk, F.E.F. Timmer, B. Geboers, E.A.C. Schouten, J. Opperman, H.J. Scheffer, J.J.J. Vries, R.J. Swijnenburg, K.S. Versteeg, B.I. Lissenberg-Witte, M.P. van den Tol, M.R. Meijerink, Thermal Ablation Compared to Partial Hepatectomy for Recurrent Colorectal Liver Metastases: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study, Cancers 13(11) (2021).","DOI":"10.3390\/cancers13112769"},{"issue":"9","key":"3598_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1055\/a-0598-5134","volume":"190","author":"AH Mahnken","year":"2018","unstructured":"A.H. Mahnken, A.M. K\u00f6nig, J.H. Figiel, Current Technique and Application of Percutaneous Cryotherapy, Rofo 190(9) (2018) 836-846.","journal-title":"Rofo"},{"key":"3598_CR12","doi-asserted-by":"crossref","unstructured":"H.J. Bang, P.J. Littrup, B.P. Currier, D.J. Goodrich, M. Choi, L.K. Heilbrun, A.C. Goodman, Percutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations, ISRN Minim Invasive Surg 2012 (2012).","DOI":"10.5402\/2012\/942364"},{"issue":"12","key":"3598_CR13","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.jvir.2013.06.025","volume":"24","author":"PJ Littrup","year":"2013","unstructured":"P.J. Littrup, H.J. Bang, B.P. Currier, D.J. Goodrich, H.D. Aoun, L.K. Heilbrun, B.A. Adam, Soft-tissue cryoablation in diffuse locations: feasibility and intermediate term outcomes, J Vasc Interv Radiol 24(12) (2013) 1817-25.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"3598_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2214\/AJR.20.22861","volume":"217","author":"A Parvinian","year":"2021","unstructured":"A. Parvinian, J.J. Schmitz, B.T. Welch, T.D. Atwell, J.M. Morris, D.A. Woodrum, A.N. Kurup, A Single-Institution Experience in Percutaneous Image-Guided Cryoablation of Lymph Node Metastases, AJR Am J Roentgenol 217(1) (2021) 152-156.","journal-title":"AJR Am J Roentgenol"},{"key":"3598_CR15","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.2147\/OTT.S189897","volume":"12","author":"Y Wang","year":"2019","unstructured":"Y. Wang, X.H. He, L.C. Xu, H.Z. Huang, G.D. Li, Y.H. Wang, W.T. Li, G.Z. Wang, CT-guided cryoablation for unresectable pelvic recurrent colorectal cancer: a retrospective study, Onco Targets Ther 12 (2019) 1379-1387.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"3598_CR16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.radcr.2021.02.055","volume":"16","author":"ME Nance","year":"2021","unstructured":"M.E. Nance, M.R. Wakefield, A.P. Bhat, R.M. Davis, Image-guided percutaneous cryo-ablation of peri-urethral unresectable recurrent pelvic malignancy: A case report and brief review, Radiol Case Rep 16(5) (2021) 1227-1232.","journal-title":"Radiol Case Rep"},{"issue":"2","key":"3598_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00270-019-02341-3","volume":"43","author":"G Tsoumakidou","year":"2020","unstructured":"G. Tsoumakidou, K. Mandralis, A. Hocquelet, R. Duran, A. Denys, Salvage Lymph-Node Percutaneous Cryoablation: Safety Profile and Oncologic Outcomes, Cardiovasc Intervent Radiol 43(2) (2020) 264-272.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"3598_CR18","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jvir.2012.03.002","volume":"23","author":"HJ Bang","year":"2012","unstructured":"H.J. Bang, P.J. Littrup, D.J. Goodrich, B.P. Currier, H.D. Aoun, L.K. Heilbrun, U. Vaishampayan, B. Adam, A.C. Goodman, Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation, J Vasc Interv Radiol 23(6) (2012) 770-7.","journal-title":"J Vasc Interv Radiol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03598-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-022-03598-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03598-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T05:11:34Z","timestamp":1660799494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-022-03598-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,2]]},"references-count":18,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["3598"],"URL":"https:\/\/doi.org\/10.1007\/s00261-022-03598-y","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,2]]},"assertion":[{"value":"23 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant (non-) financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}